entacapone


Also found in: Medical, Wikipedia.
Related to entacapone: amantadine, pramipexole, Selegiline
Translations

entacapone

n entacapona
English-Spanish/Spanish-English Medical Dictionary Copyright © 2006 by The McGraw-Hill Companies, Inc. All rights reserved.
References in periodicals archive ?
BIPARK-1 was a Phase III, randomised, double-blind placebo- and active-controlled study of opicapone as an adjunct to levodopa therapy in which 600 patients with Parkinson's disease and motor fluctuations received once-daily opicapone (5 mg, 25 mg, or 50 mg), placebo, or 200 mg doses of the COMT inhibitor entacapone for 14 to 15 weeks.
Neurocrine Biosciences Inc submits opicapone NDA with FDA as adjunctive treatment for Parkinson's disease
Potential of microemulsified entacapone drug delivery systems in the management of acute Parkinson's disease.
Biopharmaceutical Process of Diclofenac Multiparticulate Systems for Chronotherapy of Rheumatoid Arthritis/Romatoid Artritin Kronoterapisinde Diklofenak Cok Birimli Sistemlerin Biyofarmasotik Sureci
of Clarithromycin Extended Release Tablets 500 mg and Entacapone Immediate Release tablets 200 mg.
Lannett announces expanded agreement with HEC Pharm Group
Dosage reduction, monotherapy, or discontinuation in these patients could be helpful and could be replaced by selegiline, amantadine, or entacapone, which have no effects on EDS [45],[52] and may even reduce or resolve EDS.[4],[28],[52],[53],[54] Although clonazepam is the mainstay of treatment for RBD, given its associated risks, benzodiazepine use should generally be avoided in PD patients with EDS.
Excessive Daytime Sleepiness in Parkinson's Disease: Clinical Implications and Management
(1,20) In general, these complications are managed by the addition of a dopamine agonist, MAO-B inhibitor, or a catechol-O-methyltransferase (COMT) inhibitor (entacapone).
Parkinson's disease: A treatment guide: By following this stepwise approach, you can confidently incorporate newer agents into your armamentarium with little or no consultation with subspecialists
levodopa+benserazide, pramipexole (B) levodopa+benserazide, Dysphagia, pramipexole, sleep disorders, entacapone and depression clonazepam, zolpidem escitalopram Others (2) (C) levodopa+benserazide, pramipexole Sleep disorders Others (1) (D) Dysphagia, dysphonia, perspiration, levodopa+benserazide, hypotension, pramipexole urinary Others (6) incontinence and sleep disorders.
Perceptions of Individuals with Parkinson's Disease about Quality of Life/Percepciones de pacientes con enfermedad de Parkinson sobre la calidad de vida/Percepcoes de pacientes com doenca de Parkinson sobre a qualidade de vida
All participants were treated with levodopa, and additional antiparkinsonian therapy consisted of oral dopamine agonists (pramipexole and ropinirole), COMT inhibitors (entacapone and tolcapone), amantadine, subcutaneous apomorphine infusion, and deep brain stimulation.
The Impact of Living with Parkinson's Disease: Balancing within a Web of Needs and Demands
His current medications include alprostadil, amantadine, carbidopa/levodopa, entacapone, loratadine, midodrine, oxybutynin, ropinirole, and simvastatin.
Incidental Thrombus in Transit Causing Embolic Stroke
Impairment of tanshinol methylation by entacapone, a potent catechol-O-methyltransferase inhibitor, caused 35% and 43% increase of tanshinol AUC with oral and intravenous administration of tanshinol to rats, respectively [7].
Salvia miltiorrhiza Roots against Cardiovascular Disease: Consideration of Herb-Drug Interactions
(46) Although lacking empirical evidence, catechol-O-methyltransferase (COMT) inhibitors, such as entacapone, have an anti-craving affect and are used by some clinicians to improve adherence with buprenorphine.
What clinicians need to know about treating opioid use disorder: choose medication and non-medication options to fight abuse and relapse
Drug Mechanism of action L-DOPA DA precursor L-DOPA + benserazide or carbidopa DA precursor + peripheral dopa- decarboxylase inhibitor Bromocriptine, pergolide, DA receptor agonists pramipexole, ropinirole Selegiline, rasagiline Monoamine oxidase B inhibitors Increase of DA release and Amantadine glutamate NMDA receptor antagonist Trihexyphenidyl, benztropine Muscarinic receptor antagonists Catechol-O- Entacapone, tolcapone methyltransferase inhibitors Adapted from [108].
Melatoninergic System in Parkinson's Disease: From Neuroprotection to the Management of Motor and Nonmotor Symptoms
Dictionary browser ?
Full browser ?